TMO — tear sheet

The engine's document-constrained review lands at an Overweight rating with moderate conviction, below its strongest tier. The core evidence it cites is management's 8-K Item 2.02 press release (July 23, 2026): second-quarter revenue grew 10% to $11.99 billion including 5% organic growth, GAAP diluted EPS grew 9% to $4.68, and adjusted EPS grew 13% to $6.03. The QuantOrb money-flow snapshot (2026-09-17 session) shows MFI 67.35 with a CONTINUATION signal, strength 0.6449 — which the source labels a screen output, not a recommendation. Per the engine's read of the quantorb 13F dataset, the five tracked filers (holdings as of 2026-03-31) net to roughly +2.8% of tracked shares, with 1832 Asset Management's +725,093-share add the largest move. The engine caps conviction because valuation and price levels are not available in provided documents, roughly half of Q2 headline growth was non-organic, and the ~$1.35 GAAP-versus-adjusted EPS wedge lacks an itemized reconciliation in the corpus. Sources: EIGHTK (8-K press release, 2026-07-23); FACTS (QuantOrb snapshot, 2026-09-17); THIRTEENF (quantorb 13F-HR, 2026-03-31).

Source: SEC 13F-HR holdings (as of 2026-03-31) via quantorb filers data — quarter-end snapshots, statutory lag up to 45 days

Quarter-end 13F-HR snapshot for TMO as tracked in the quantorb filers dataset (5 institutional filer rows on file; positions as of 2026-03-31, a quarter-end snapshot subject to the statutory 13F reporting lag of up to 45 days). Quarter-over-quarter share changes where the dataset carries them:

This is the dataset's tracked top-holder snapshot, not an exhaustive list of 13F filers; it is a periodic regulatory disclosure, not real-time portfolio data.

Management's press release (SEC 8-K Item 2.02, July 23, 2026) carries a positive tone. Chairman and CEO Marc N. Casper cited 'outstanding performance in the second quarter,' the 'proven growth strategy' and the 'PPI Business System,' adding that 'end markets continue to strengthen' with 'continued share gain.' The release states customer activity across end markets continued to strengthen, and Casper said the company is 'well positioned to deliver a great 2026.' Reported items for the quarter ended June 27, 2026: revenue grew 10% to $11.99 billion (5% organic), GAAP diluted EPS grew 9% to $4.68, and adjusted EPS grew 13% to $6.03. A visible catalyst in the release is the product cycle: next-generation Orbitrap platforms with AI-driven analytics introduced at the American Society for Mass Spectrometry conference. Numeric full-year guidance and the Q3 2026 earnings date are not available in provided documents; the engine treats the Q3 print as its confirmation gate. Sources: EIGHTK (SEC 8-K Item 2.02 press release, 2026-07-23); FACTS (QuantOrb engine outputs).

The SEC 10-K (filed 2026-02-26) warns growth would be hurt if served markets decline, do not grow as anticipated or are cyclical, and that inflation, significant in 2025, continues at elevated levels; the engine treats this as cautionary language but notes the Q2 print did not refute a structural risk. Its risk review flags earnings quality: GAAP EPS grew 9% against 10% revenue growth, the ~$1.35 adjusted-versus-GAAP wedge widened about $0.30 year over year, and the corpus has no itemized reconciliation. Roughly half of Q2 headline growth was non-organic. Per the quantorb 13F dataset, the five-filer snapshot (2026-03-31) is stale and partial; Pictet (-16.3%) and Flossbach von Storch (-10.3%) reduced, predating the Q2 release. The engine also notes price, valuation, balance-sheet, cash-flow and guidance data are not available in provided documents, and designates a money-flow signal flip, organic growth below the Q2 5% pace, or a widening wedge as de-risk conditions. Sources: FILING (SEC 10-K, 2026-02-26); EIGHTK (8-K press release, 2026-07-23); THIRTEENF (quantorb 13F-HR, 2026-03-31); FACTS (QuantOrb snapshot, 2026-09-17).